Let’s learn from our neighbors from the North as we get the menthol flavor out of cigarettes

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In the trenches on the medicine wards and smoking cessation clinics at Parkland Hospital  and UT Southwestern Simmons Cancer Center, I see firsthand the increased prevalence of smoking in the Black population, their frequent use of menthol, and the ravaging toll it takes on their health.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
David Balis, MD
Director, Smoking Cessation Clinics, Parkland Hospital, UT Southwestern Simmons Cancer Center; Professor, General Internal Medicine, UT Southwestern
Table of Contents

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
FDA approved AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-low (IHC 1+ or IHC 2+/ISH-) or HER2-ultralow (IHC 0 with membrane staining) breast cancer, as determined by the FDA approved test, that has progressed on one or more endocrine therapies in the metastatic setting.
David Balis, MD
Director, Smoking Cessation Clinics, Parkland Hospital, UT Southwestern Simmons Cancer Center; Professor, General Internal Medicine, UT Southwestern

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login